新股消息 | 麦科田拟港股IPO获中国证监会接收材料

Group 1: Company Overview - 麦科田 is planning an IPO in Hong Kong and has a comprehensive product portfolio that meets clinical needs across various healthcare settings [1] - 盛威时代 ranks 14th in China's ride-hailing service market based on 2024 GTV and has undertaken digital projects in 17 provinces [2] - 中润光能 is a leading manufacturer of photovoltaic cells, with a market share of 14.6% in global shipments and 18.3% among specialized manufacturers [3] Group 2: Product and Service Offerings - 麦科田 has commercialized over 50 life support products, 80 minimally invasive products, and 210 in vitro diagnostic products, serving over 6,000 hospitals in China [1] - 盛威时代 provides urban ride-hailing and intercity passenger transport services, collaborating with various transport companies to offer customized services [2] - 中润光能 has expanded vertically into the photovoltaic module industry while maintaining a focus on photovoltaic cell production [3] Group 3: Market Presence - 麦科田's products are available in over 140 countries and regions, covering approximately 90% of China's top-tier hospitals [1] - 盛威时代 has established operations in over 30 provinces and regions, enhancing its service offerings [2] - 中润光能 operates in over 32 countries and regions, serving more than 1,000 customers globally [3]